CSNews

Philip Morris International Requests Continued Modified-Risk Claim for IQOS

SILVER SPRING, Md. — Philip Morris International Inc. (PMI) made its case to continue to market its heat-not-burn IQOS as a ...
Agence France-Presse

Philip Morris International Urges U.S. Food and Drug Administration Advisory Committee to Recommend Continued Marketing of IQOS as Modified Risk Product

Experts from Philip Morris International Inc. (NYSE: PM) presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC). The committee, comprised of independent scientific ...

Philip Morris raises EPS growth outlook to 13.5%-15.1% in dollar terms as smoke-free brands accelerate

Discover Philip Morris International’s record Q3 2025 results, smoke-free growth outlook, and raised EPS guidance.
Hosted on MSN

Philip Morris Seeks FDA Approval To Keep IQOS Modified Risk Designation For Later Versions Of Device

Philip Morris International Inc. (PM) said on Wednesday that its experts met with the Tobacco Products Scientific Advisory Committee on October 7 as it seeks to continue marketing versions of its IQOS ...
Medscape

HeatSticks Not Such a Hot Solution to Tobacco-Related Disease, FDA Panel Says

A US Food and Drug Administration (FDA) advisory committee has determined that a new "heat-not-burn" tobacco device does not definitively reduce the risk for tobacco-related disease, but does reduce ...
Hosted on MSN

You Won’t Believe What’s Smart Now (Spoiler: It’s Everything!)

More information on www.iqos.com. This product is not risk-free and provides nicotine, which is addictive. Only for use by adults who would otherwise continue to smoke or use other nicotine products.